Effect of L-arginine supplement on liver regeneration after partial hepatectomy in rats by Tsuyoshi Kurokawa et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Kurokawa et al. World Journal of Surgical Oncology 2012, 10:99
http://www.wjso.com/content/10/1/99RESEARCH Open AccessEffect of L-arginine supplement on liver
regeneration after partial hepatectomy in rats
Tsuyoshi Kurokawa1,6*, Jun An1,2, Koji Tsunekawa3,4, Yoshiharu Shimomura5, Shunsuke Kazama5, Naohisa Ishikawa3,
Toshiaki Nonami1 and Satoru Sugiyama4Abstract
Background: Nitric oxide (NO) has been reported to be a key mediator in hepatocyte proliferation during liver
regeneration. NO is the oxidative metabolite of L-arginine, and is produced by a family of enzymes, collective
termed nitric oxide synthase (NOS). Thus, administration of L-arginine might enhance liver regeneration after a
hepatectomy. Another amino acid, L-glutamine, which plays an important role in catabolic states and is a crucial
factor in various cellular and organ functions, is widely known to enhance liver regeneration experimentally. Thus,
the present study was undertaken to evaluate the effects of an L-arginine supplement on liver regeneration, and to
compared this with supplementation with L-glutamine and L-alanine (the latter as a negative control), using a rat
partial hepatectomy model.
Methods: Before and after a 70% hepatectomy, rats received one of three amino acid solutions (L-arginine,
L-glutamine, or L-alanine). The effects on liver regeneration of the administered solutions were examined by
assessment of restituted liver mass, staining for proliferating cell nuclear antigen (PCNA), and total RNA and DNA
content 24 and 72 hours after the operation.
Results: At 72 hours after the hepatectomy, the restituted liver mass, the PCNA labeling index and the DNA
quantity were all significantly higher in the L-arginine and L-glutamine groups than in the control. There were no
significant differences in those parameters between the L-arginine and L-glutamine groups, nor were any
significant differences found between the L-alanine group and the control.
Conclusion: Oral supplements of L-arginine and L-glutamine enhanced liver regeneration after hepatectomy in
rats, suggesting that an oral arginine supplement can clinically improve recovery after a major liver resection.
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The result of extensive hepatectomy has been greatly
advanced through operative techniques and periopera-
tive management. That strategy has been maintained by
the capacity for liver regeneration. Under normal condi-
tions, the basal hepatocyte proliferation rate is low, and
mitosis seldom occurs. However, after an event involving
a substantial loss of hepatic tissue such as that found in
severe viral hepatitis or a major hepatectomy, cell div-
ision leads to intense tissue growth until regeneration* Correspondence: tsuyok@masuko.or.jp
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reproduction in any medium, provided the oroccurs, with the energetic and synthesis capacity being
essentially maintained. This regenerative process is ac-
companied by compensatory cellular hyperplasia and
hypertrophy, and is controlled and mediated by nutri-
ents and growth factors. If liver regeneration after major
hepatectomy could be enhanced artificially, the cases in
which hepatectomy for liver cancers can be used would
be extended, with improved patient prognoses.
Nitric oxide (NO) is known to be a multifunctional me-
diator, regulating blood pressure, gene expression, apop-
tosis, and mitogenesis in essentially every organ and tissue
[1-3]. NO is enzymatically synthesized from L-arginine
(L-Arg) by three nitric oxide synthase (NOS) isoforms:
neuronal (n)NOS, inducible (i)NOS and endothelial (e)
NOS. eNOS is a crucial mediator of vascular tone andral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pathophysiology [4]. NO has been reported to reduce
organ injury and enhance liver regeneration by experi-
mentally modulating hepatic macrohaemodynamics [5].
Recently, there have been studies assessing whether
delivery of a specific amino acid can improve patient
outcome, as some amino acids are precursors of many
important biologic compounds essential for a normal
functioning of the human organism [6]. Furthermore,
these supplements can be taken orally to provide ef-
fective clinical availability. There have been no reports
describing whether or not L-Arg enhances liver regener-
ation after hepatectomy. In the present study, we evalu-
ated the effect of oral administration of L-Arg on liver
regeneration after hepatectomy in rats.
Methods
Rat hepatectomy model
The study was approved by the Animal Care Committee
of Aichi Medical University.
Seven-week-old male Wistar rats weighing between 170
and 190 g were purchased (SLC, Shizuoka, Japan) and
habituated to the laboratory animal room for 1 week. All
rats received humane care. They were kept in a climate-
controlled room under 12-hour light/dark cycles with
free access to food and tap water throughout the studies.
The rats were randomized into four groups (n = 12 in
each group): control, L-Arg, L-glutamine (L-Gln) and
the negative control L-alanine (L-Ala) (all amino acids
from Wako, Osaka, Japan). Each group was divided into
two subgroups (n = 6 in each subgroup) according to
sample collection time (24 and 72 hours after hepatect-
omy). 10% L-Arg, 10% L-Gln or 10% L-Ala (1 ml/100 g
body weight) was administered orally to the rats 15 min-
utes before a partial hepatectomy was carried out. The
control group received no solution.
Under pentobarbital anesthesia (50 mg/kg body weight,
administered intraperitoneally.), the abdomen of each rat
was opened, and the median and left lobes of the liver
were removed, using the standard Higgins and Anderson
technique [7]. Rats in the control group underwent ab-
dominal incision only.
Each rat in the treatment groups was also given the
same amino acid after the surgery; the amino acid was
added to the drinking tap water at a concentration of 1%.
At 24 and 72 hours after hepatectomy, the tissue used
for the following experiments was collected. After each
rat was anesthetized with pentobarbital sodium (50 mg/kg
body weight intraperitoneally), the rats were killed.
Sample collection
Small liver samples were collected from each rat, then
frozen immediately and stored in liquid nitrogen until
use for total DNA and RNA assays.After the rats were killed, the blood was removed with
saline, then a 4% paraformaldehyde solution (Wako,
Osaka, Japan) dissolved in phosphate buffer was infused
into the circulation via the left ventricle. The liver tissues
were removed and fixed in 4% paraformaldehyde solu-
tion for 1 day. They were then hydrated through a
graded alcohol and xylene series and embedded in paraf-
fin wax. The samples were cut into sections 3 μm thick.
Restituted liver mass
At the time of partial hepatectomy, the entire resected
portion of the liver (designated B) was weighed. This
weight was taken to be 30% of the total pre-hepatectomy
liver weight, thus enabling calculations of the total liver
weight (A). Once the rats were killed, the remaining liver
portion (C) was excised and weighed. These data were
expressed as a percentage of the ratio of remnant liver
weight divided by the calculated total pre-hepatectomy
weight and multiplied by 100 to yield a percentage resti-
tution of liver mass [8]: Restituted liver mass (%) = [C-
(A-B)/A] × 100.
Staining for proliferating cell nuclear antigen
Hepatocyte regeneration was analyzed using immuno-
histochemical detection of proliferating cell nuclear anti-
gen (PCNA) with a commercial kit (LSAB2 Kit; Dako,
Kyoto, Japan). The sections were blocked against en-
dogenous peroxidase using 3% H2O2 for 10 min, and
rinsed in 0.01 mol/l TBS (50 mmol/l Tris–HCl, 0.15
mol/l NaCl, pH 7.6). Sections were incubated at 4°C
overnight with primary mouse monoclonal anti-PCNA
antibody (Dako, Kyoto, Japan) diluted 100 times in 0.01
mol/l PBS. Nuclear staining was performed using
hematoxylin. Five fields per slide at 100× magnification
were randomly selected, and the total hepatocytes per
field were counted. The mean percentages of PCNA-
positive hepatocytes were calculated and compared be-
tween the different groups.
Total RNA and DNA assays
The liver tissue that had been stored in liquid nitrogen
was removed and ground to a semi-powder at the same
(liquid nitrogen) temperature. Total RNA and genomic
DNA were then extracted from the semi-powdered tis-
sue using commercial products (SV Total RNA Isolation
System and Wizard SV Genomic DNA Purification Sys-
tem, respectively; both Promega Co., Madison, WI, USA),
following the manufacturer’s instructions. The total RNA
and genomic DNA content were determined by spectro-
photometry at 260 nm.
Statistical analysis
Data (given as mean ± standard error of the mean) were
examined for significance using Kruskal-Wallis one-way
Kurokawa et al. World Journal of Surgical Oncology 2012, 10:99 Page 3 of 6
http://www.wjso.com/content/10/1/99analysis of variance, followed by Scheffé's method, and
significance was set at P < 0.05.
Results
Restituted liver mass
No significant differences in liver mass were evident in
any group at 24 hours after partial hepatectomy. There
were significantly higher levels of restituted liver mass
in the L-Arg (52.3 ± 4.2%; P < 0.01) and L-Gln (45.5 ±
1.7%; P < 0.05) groups than in the control (37.3 ± 4.1%)
and L-Ala (36.0 ± 3.0%) groups at 72 hours after partial
hepatectomy (Figure 1). There were no significant dif-
ferences in restituted liver mass between the L-Arg
and L-Gln groups.
Immunohistochemical staining results for proliferating
cell nuclear antigen
Representative photographs of PCNA immunohisto-
chemical staining in each group are shown in Figure 2A.
Hepatic regenerative activity, expressed as the PCNA la-
beling index (%), was significantly improved in the L-
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Figure 1 Restituted liver mass at 24 and 72 hours after partial
hepatectomy. No significant differences in liver mass were evident
at 24 hours after rats in each group underwent partial hepatectomy.
There were significantly higher values found for the restituted liver
mass in the L-Arg and L-Gln groups than in the control and L-Ala
groups at 72 hours after partial hepatectomy. There were no
significant differences in the restituted liver mass between the L-Arg
and L-Gln groups. *: P< 0.05 and **: P< 0.01, compared with controls
(n = 6 each).P < 0.01) groups versus the control (30.0 ± 4.5%), but
remained unchanged in the L-Ala (32.0 ± 3.0%) group at
24 hours after partial hepatectomy. Moreover, the L-Arg
(59.0 ± 1.9%; P < 0.01) and L-Gln (53.1 ± 3.5%; P < 0.05)
groups were also significantly improved compared with
the control (40.1 ± 3.4%) and the L-Ala (43.1 ± 2.7%)
groups at 72 hours after partial hepatectomy (Figure 2B).
There were no significant differences in the PCNA label-
ing index between the L-Arg and L-Gln groups.
Total RNA and DNA assay
Both the total RNA and the genomic DNA were mea-
sured as milligrams per gram of liver tissue. For the
genomic DNA levels, no significant differences were
detected at 24 hours after partial hepatectomy in each
group, but at 72 hours, significantly increased levels of
genomic DNA were found in the L-Arg (P < 0.05) and
L-Gln (P < 0.05) groups compared with the control group
(Figure 2A). There were no significant differences in the
DNA levels between the L-Arg and L-Gln groups. The
DNA level in the L-Ala group also increased, but this
was not significant.
For total RNA levels, no significant differences were
found between the control and the experimental groups
at either 24 or 72 hours after the partial hepatectomy
(Figure 3).
Discussion
Amino acids are the essential building blocks of all
mammalian cells. In addition to their role in protein
synthesis, amino acids also play an important role as en-
ergy fuel, precursors of a variety of metabolites, and as
signaling molecules. Recently, there has been interest in
assessing whether delivery of specific amino acids can
improve patient outcome under various pathological
conditions [6]. Gln is the most abundant amino acid in
human muscle and plasma. Apart from providing nitro-
gen for protein synthesis, Gln is a precursor for nucleic
acids, nucleotides, and the major antioxidant glutathione
[9]. Recent data also indicate that Gln functions as a sig-
naling molecule [10], particularly under catabolic condi-
tions. Yoshida et al. [11] reported beneficial effects of
Gln on DNA and on the protein synthesis of remnant
liver in the 70% rat hepatectomy model. Since then,
similar findings have been reported by a number of
investigators [12,13]. In the present study, we evaluated
the effects of L-Gln on liver regeneration, as measured
by a restituted liver mass, the PCNA labeling index, and
total DNA, and found basically equivalent results. Al-
though Gln was administered intravenously in previous
reports, we found oral administration of L-Gln to be
similarly beneficial. Because oral supplementation of L-
Gln is considered safer than intravenous infusion, this
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Figure 2 Proliferating cell nuclear antigen (PCNA) immunohistochemical staining in liver at 24 and 72 hours after partial hepatectomy.
Representative photographs of PCNA immunohistochemical staining in each group were shown (original magnification× 100). Hepatic
regenerative activity, expressed as the PCNA labeling index (%), was significantly improved in the L-Arg and L-Gln groups versus the control, but
remained unchanged in the L-Ala group at 24 hours after partial hepatectomy. The L-Arg and L-Gln groups were also significantly improved
compared with the control and L-Ala groups at 72 hours after partial hepatectomy. There were no significant differences in the PCNA labeling
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Figure 3 Quantification of genomic DNA and total RNA at 24 and 72 hours after partial hepatectomy. (A) No significant differences in
the genomic DNA levels were found at 24 hours after partial hepatectomy in each group. However, at 72 hours after partial hepatectomy,
significantly increased levels of genomic DNA were found in the L-Arg and L-Gln groups compared with the control group. There were no
significant differences in DNA levels between the L-Arg and L-Gln groups. The DNA level in the L-Ala group also tended to increase, but not
significantly. (B) No significant differences were found in total RNA levels between the control and the experimental groups at either 24 or
72 hours after a partial hepatectomy. *P< 0.05 compared with each control (n = 6 each).
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increasing blood flow by signaling smooth muscles to
relax. A beneficial effect of NO on liver regeneration
through an increase in hepatic arterial flow has been
reported [5]. Studies have also shown that NO derived
from eNOS regulates sinusoidal endothelial cell prolifera-
tion [14] and hepatocyte proliferation [4]. Carnovale et al.
[15] showed that the hepatocyte iNOS level was increased
after hepatectomy, and that NO derived from iNOS
enhanced hepatic DNA synthesis, which had formerly been
blocked by inhibiting iNOS expression. Observations of
impaired liver regeneration and hepatocyte survival in
iNOS knockout mice provide additional proof for the im-
portance of NO-mediated signaling in liver regeneration
[16]. It has also been shown that nitric oxide production
contributes to hepatocyte proliferation in normal juvenile
rats [17]. Although the mechanism of NO contribution to
hepatocyte proliferation is not yet fully understood, it is
known that NO derived from both eNOS and iNOS
enhances liver regeneration.
Arg supplementation has been identified as advanta-
geous in wound healing in experimental animals and
humans [18,19]. The beneficial effects of Arg supple-
mentation on wound healing have been attributed to
enhanced synthesis of NO by NOS. NO is synthesized
by both parenchymal and nonparenchymal cells of the
liver [20]. The aim of the present study was to clarify
whether direct administration of L-Arg has any effect on
liver regeneration. We found that increases in restituted
liver mass enhanced by L-Arg and L-Gln supplementa-
tion were associated with increases in the quantity of
total hepatic DNA. Both restituted liver mass and DNA
quantity were significantly higher in the L-Arg and L-Gln
groups than in the control, suggesting that the hepatic
regeneration was accompanied by cell proliferation.
However, the hepatic regeneration was not accompanied
by increases in the total RNA quantity, suggesting that
the rate of protein synthesis might be in steady state.
L-Ala was used as the negative control to match the
energy and amino acid supply to L-Arg or L-Gln [21].
The significant differences found between L-Arg/L-Gln
and L-Ala in the present study also reveals the specific
functions of L-Arg and L-Gln in improving liver re-
generation beyond the functions of simple nutrients.
One report has shown different effects of L-Arg and L-
Gln on liver regeneration in rats receiving total paren-
teral nutrition after hepatectomy [22]. To reveal the dif-
ferent mechanisms between L-Arg and L-Gln, another
study containing an experimental group given both L-
Arg and L-Gln together might be useful. Further study is
warranted.
In our study, we found that L-Arg seems to have a
similar potential for liver regeneration to that of L-Gln.
Both amino acids proved effective even when orallyadministered, which is likely to facilitate clinical use. In
our study, we gave rats oral 10% L-Arg (1 ml/100 g body
weight) before hepatectomy and also administered it
after the operation by adding it to tap water at a concen-
tration of 1%. Witte et al. [23] reported that although
the doses of Arg (20–50 mg/100 g/day) must be consid-
ered pharmacological, there is a notable lack of toxic
side-effects. In light of their knowledge, our doses were
two to five times higher on the operation day and about
twice as high afterwards. However, when excessive amino
acids are administered to patients with an impaired liver
function such as liver cirrhosis, the increased ammonia
levels can result in hepatic encephalopathy. Therefore,
both the potential risks and benefits of L-Gln or L-Arg
must be considered before treatment.
Conclusion
In the present study, we found that both L-Arg and L-
Gln enhanced liver regeneration after 70% rat hepatect-
omy. These results may contribute to the treatment of
patients in need of major liver resection.
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